Amneal Pharmaceuticals Inc (FRA:2DT)
€ 7.25 -0.05 (-0.68%) Market Cap: 2.31 Bil Enterprise Value: 4.84 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 66/100

Amneal Pharmaceuticals Inc at Raymond James Institutional Investors Conference (Virtual) Transcript

Mar 01, 2021 / 08:00PM GMT
Release Date Price: €4.55 (+12.97%)
Elliot Henry Wilbur
Raymond James & Associates, Inc., Research Division - Senior Research Analyst

Good afternoon. Welcome to the Amneal Pharmaceuticals virtual presentation at Raymond James Annual Institutional Investor Conference. Pleased to have the company joining us this afternoon. Representing the company, members of management, we have Chirag Patel, company's Co-CEO and Co-Founder; along with Chintu Patel, also company's Co-CEO and a Co-Founder; and Tasos Konidaris, the company's Chief Financial Officer. Amneal is a leading U.S.-based generics company, founded in 2002; now, the fourth largest player in the industry. Has consistently moved up the generics value chain over the past several years, increasingly focused on high barrier to entry, specialty generics, biosimilars and specialty brands.

So thank you, gentlemen. Welcome. I appreciate you joining us this afternoon.

Chirag K. Patel;Elliot Henry Wilbur
Amneal Pharmaceuticals, Inc. - Co-Founder, Co-CEO, President & Director;Raymond James

Thank you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot